Notes in Ureter and renal pelvis

To Subscribe, use this Key

Status	Last Update	Fields
Published	02/18/2024	GU \| Ureter & renal pelvis \| 1.1 \| Pathologic classification
Published	02/18/2024	GU \| Ureter & renal pelvis \| 1.2 \| Epidemiology
Published	02/18/2024	GU \| Ureter & renal pelvis \| 1.4.1 \| Biologic behaviour
Published	02/18/2024	GU \| Ureter & renal pelvis \| 1.3 \| Risk factors
Published	02/18/2024	GU \| Ureter & renal pelvis \| 1.6 \| Clinical presentation
Published	02/18/2024	GU \| Ureter & renal pelvis \| 2.1 \| Workup
Published	02/18/2024	GU \| Ureter & renal pelvis \| 2.2 \| Staging (AJCC 8th edition 2017)
Published	02/18/2024	GU \| Ureter & renal pelvis \| 3.1 \| Management
Published	02/18/2024	GU \| Ureter & renal pelvis \| 3.2 \| Surgical principles
Published	02/18/2024	GU \| Ureter & renal pelvis \| 3.3 \| Role of radiotherapy
Published	02/18/2024	GU \| Ureter & renal pelvis \| 4.1 \| Follow up
Published	02/18/2024	GU \| Ureter & renal pelvis \| 5 \| Prognosis
Published	02/18/2024	GU \| Ureter & renal pelvis \| 1.5 \| Macroscopic and microscopic appearance
Published	02/18/2024	GU \| Ureter & renal pelvis \| 2.3 \| DDx
Published	02/18/2024	GU \| Ureter & renal pelvis \| 1.4.2 \| Field cancerisation
Published	02/18/2024	GU \| Ureter & renal pelvis \| 6.1 \| RT technique \| Definitive
Published	02/18/2024	GU \| Ureter & renal pelvis \| 6.2 \| RT technique \| Adjuvant
Published	02/18/2024	GU \| Ureter & renal pelvis \| 3.4 \| Role of chemotherapy
Status	Last Update	Fields